US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 24, 2014 (12 years ago)

Paroxetine HCL Controlled-Release Tablets 37.5 mg

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

What was recalled

Paroxetine HCL Controlled-Release Tablets 37.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3675-3

Recalling firm
Apotex Inc.
NDC code
60505-3675-3
Origin
Canada
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1577-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Paroxetine recalls

See all
Class II · Moderate risk Terminated

PAROXETINE tablets

Reason Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine

Golden State Medical Supply Inc. NDC 60429-737-30 D-0130-2024
Class II · Moderate risk Terminated

PAROXETINE tablets

Reason Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine

Golden State Medical Supply Inc. NDC 60429-735-90 D-0129-2024
Class II · Moderate risk Terminated

PAROXETINE tablets

Reason Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine

Golden State Medical Supply Inc. NDC 60429-734-30 D-0128-2024
Class II · Moderate risk Ongoing

Paroxetine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Apotex Corp. D-0122-2024
Class II · Moderate risk Ongoing

Paroxetine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Apotex Corp. D-0121-2024